Illumina Accelerator β Full Portfolio
12 tracked investments Β· listed companies and verified rows first
NonExomics is a drug discovery company that uses a machine learning platform integrating genomics, transcriptomics, and proteomics to identify novel "noncanonical" proteins encoded across the entire human genome, including the previously unstudied 98% "dark genome." It has cataloged hundreds of thousands of such proteins and thousands of novel druggable targets associated with over 1,300 human diseases for therapeutic development.
AI & Machine LearningBiotechDeep TechHealthtechActon, US
Ruchi Chauhan(Director)
Co-investorsFormation Venture Engineering
BioAmp Diagnostics develops a chemistry-based rapid diagnostic pipeline (DETECT: Dual-Enzyme Trigger-Enabled Cascade Technology) that delivers infection results in minutes to guide antibiotic prescribing, initially targeting complicated urinary tract infections.
BiotechDigital HealthMedical DevicesSan Carlos, US
Tara DeBoer(Chief Executive Officer)inAngel Resendez(Director of Chemistry - Small Molecule Discovery, CSIO)in
Co-investorsBlue Bear Ventures
Illumina Ventures is a venture capital firm focused on genomics and precision health, investing in early-stage companies developing breakthrough science and technology to improve human health.
AI & Machine LearningBiotechDeep TechDigital HealthHealthtech
Co-investorsBeast Ventures
Juno is a research platform that runs unscripted, asynchronous qualitative interviews with real people and analyzes the responses at scale, connecting themes to source quotes.
AI & Machine LearningMarketing TechSaaS
Michelle Gilmore(CEO)
Co-investorsBlackbird VenturesFlying Fox VenturesAda VenturesArtesianEntrepreneur First
Juno offers an at-home vaginal microbiome test paired with results, treatment plans, and support from OB-GYNs and researchers, aimed at helping people manage vaginal symptoms and infections.
Digital HealthDirect to ConsumerFemTechHealthtechLondon, GB
Hana Janebdar(CEO)inLeighton Turner(CTO)in
Co-investorsAI SeedEntrepreneur FirstAda VenturesArtesian
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.